Literature DB >> 12114659

Columnar Cell Carcinoma of the Thyroid: MIB-1 Immunoreactivity as a Prognostic Factor.

Mitsuyoshi Hirokawa1, Michio Shimizu, Takashi Fukuya, Toshiaki Manabe, Hiroshi Sonoo.   

Abstract

We report a case of columnar cell carcinoma of the thyroid. A 47-year-old Japanese man had a nonencapsulated thyroid mass that infiltrated the surrounding tissues extensively. Seventeen months after thyroidectomy he died of respiratory failure resulting from tracheal invasion. An autopsy showed distant metastases to the liver, lung, esophagus, and pancreas. Histologically, the thyroid mass consisted of tall columnar atypical cells with marked nuclear stratification, About one-fifth of tumor cells were immunopositive for M18-1. The MIB-1 -positive index of our case was extremely high, compared with that of ordinary papillary carcinoma. This case indicates that biological growth activity in columnar cell carcinoma may be similar to that of undifferentiated carcinoma of the thyroid, since the MIB-1 -positive index is close to each other.

Entities:  

Year:  1998        PMID: 12114659     DOI: 10.1007/bf02739949

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  9 in total

1.  Thyroid carcinoma with mixed tall-cell and columnar-cell features.

Authors:  L A Akslen; J E Varhaug
Journal:  Am J Clin Pathol       Date:  1990-10       Impact factor: 2.493

2.  Columnar cell carcinoma of the thyroid. Fine needle aspiration findings in a case.

Authors:  P K Hui; J K Chan; P S Cheung; E Gwi
Journal:  Acta Cytol       Date:  1990 May-Jun       Impact factor: 2.319

3.  Columnar-cell carcinoma. Another variant of poorly differentiated carcinoma of the thyroid.

Authors:  M Sobrinho-Simões; J M Nesland; J V Johannessen
Journal:  Am J Clin Pathol       Date:  1988-02       Impact factor: 2.493

4.  Tall cell carcinoma of the thyroid gland.

Authors:  M J Hicks; J G Batsakis
Journal:  Ann Otol Rhinol Laryngol       Date:  1993-05       Impact factor: 1.547

5.  Encapsulated columnar-cell neoplasms of the thyroid. A report of four cases suggesting a favorable prognosis.

Authors:  H L Evans
Journal:  Am J Surg Pathol       Date:  1996-10       Impact factor: 6.394

6.  Columnar-cell carcinoma of the thyroid. A report of two cases of an aggressive variant of thyroid carcinoma.

Authors:  H L Evans
Journal:  Am J Clin Pathol       Date:  1986-01       Impact factor: 2.493

Review 7.  Columnar cell carcinoma of the thyroid gland: a case report and review of the literature.

Authors:  Y Mizukami; A Nonomura; T Michigishi; M Noguchi; S Nakamura; T Hashimoto
Journal:  Hum Pathol       Date:  1994-10       Impact factor: 3.466

8.  Growth activity in hyperplastic and neoplastic human thyroid determined by an immunohistochemical staining procedure using monoclonal antibody MIB-1.

Authors:  R Katoh; C E Bray; K Suzuki; A Komiyama; A Hemmi; A Kawaoi; T Oyama; T Sugai; S Sasou
Journal:  Hum Pathol       Date:  1995-02       Impact factor: 3.466

9.  The tall cell variant of papillary carcinoma of the thyroid gland. Comparison with the common form of papillary carcinoma by DNA and morphometric analysis.

Authors:  A Flint; R D Davenport; R V Lloyd
Journal:  Arch Pathol Lab Med       Date:  1991-02       Impact factor: 5.534

  9 in total
  2 in total

1.  Clinical behaviors of rare variants of papillary thyroid carcinoma are associated with survival: a population-level analysis.

Authors:  Chenghao Jiang; Tong Cheng; Xucai Zheng; Shikai Hong; Song Liu; Jianjun Liu; Jing Wang; Shengying Wang
Journal:  Cancer Manag Res       Date:  2018-03-09       Impact factor: 3.989

2.  Tumor Arrests DN2 to DN3 Pro T Cell Transition and Promotes Its Conversion to Thymic Dendritic Cells by Reciprocally Regulating Notch1 and Ikaros Signaling.

Authors:  Ipsita Guha; Avishek Bhuniya; Divanshu Shukla; Ashok Patidar; Partha Nandi; Akata Saha; Shayani Dasgupta; Nilanjan Ganguly; Sweta Ghosh; Arathi Nair; Subrata Majumdar; Bhaskar Saha; Walter J Storkus; Rathindranath Baral; Anamika Bose
Journal:  Front Immunol       Date:  2020-06-05       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.